By Paul Canelas, Business Development Director at Orbis Clinical
In Biometrics, a hiring mistake is rarely just a hiring mistake.
The wrong person in Biostatistics, Statistical Programming, or Clinical Data Management can create downstream effects that extend far beyond the individual role. Rework increases. Decisions take longer. CRO oversight suffers. Database locks can slip. Analysis timelines tighten. And as a program approaches a regulatory milestone, even relatively small delays can become expensive.
For companies making critical biometrics hires, the cost of misalignment can show up long after the offer is accepted.
The issue is not always a lack of technical ability.
In many cases, the candidate looks excellent on paper. They have the right therapeutic-area experience, strong technical credentials, and years of industry experience. The problem is misalignment between the individual’s experience and the environment in which they are being asked to perform.
Technical Expertise Is Only Part of the Equation
This challenge is particularly pronounced in emerging biotech.
A cofounder of an early-stage biotech recently described one of the biggest talent challenges he sees across small companies:
“A big piece is the culture and attitude. You can have good expertise on paper, but not the start-up mindset that's needed. There can be a lack of urgency. It is also difficult to find senior, experienced people with the right mindset and small-company experience who can become the core pillars of the company.”
That mindset distinction is important.
A technically qualified candidate can still be the wrong hire if the person is accustomed to an operating environment that is dramatically different from the one they are entering.
Small biotech companies often need people who are comfortable with ambiguity, willing to wear multiple hats, able to make decisions without layers of infrastructure, and capable of moving quickly when timelines change. They need people who take ownership.
For senior hires in particular, the company may not simply be hiring someone to perform a function. It may be hiring someone who will help build that function. That is why evaluating biometrics hires requires looking at how someone has worked, not only where they have worked.
The Big Pharma-to-Biotech Transition
This is one of the most common areas where misalignment can occur.
Someone coming from a large pharmaceutical company may have outstanding experience. But large organizations often provide established processes, significant infrastructure, specialized teams, and clearly defined responsibilities. A small biotech may offer almost the opposite.
Instead of managing one narrow piece of a program, the individual may need to:
Develop processes that do not yet exist.
Manage and challenge CROs and other vendors.
Move between strategic and hands-on responsibilities.
Work across Clinical, Regulatory, Data Management, Programming, and Statistics.
Make decisions with incomplete information.
Adjust quickly as priorities change.
Take direct ownership when something goes wrong.
Neither environment is inherently better. The question is whether the candidate's experience and working style match what the company actually needs.
This is why simply asking, “Has this person worked on an NDA or BLA?” may not tell you enough.
A better question is:
What did they actually own?
Were they personally responsible for driving deliverables and solving problems, or were they one member of a much larger infrastructure?
That difference often becomes visible at the worst possible time: during database lock, analysis, regulatory preparation, or submission.
Why Misalignment Is Particularly Costly for Biometrics Hires
Biometrics sits at the center of clinical data and regulatory decision-making.
When the team is properly aligned, Biostatistics, Statistical Programming, and Clinical Data Management work together to keep data clean, analyses accurate, and deliverables moving toward critical milestones.
When they are not aligned, the consequences can accumulate quickly.
A seemingly small issue can lead to:
Programming rework → dataset inconsistencies → additional QC cycles → TLF revisions → delayed analysis → pressure on submission timelines.
Problems in Data Management can delay database lock. Programming issues can create additional validation and QC work. Statistical decisions made too late can ripple across programming and reporting.
The closer a company gets to a major regulatory milestone, the more expensive those delays become.
The true cost of the wrong hire therefore isn't simply recruiting fees, salary, or contractor spend. It is the potential cost of lost time.
For biometrics hires, that makes alignment a program risk consideration, not simply a recruiting consideration.
Start-Up Mindset Needs to Be Evaluated
Traditional screening tends to focus heavily on technical qualifications:
Does the candidate know the therapeutic area?
Have they supported the appropriate phase?
Have they worked with the necessary systems?
Have they supported regulatory submissions?
Those questions are essential, but for emerging biotech they are not enough.
Companies also need to understand how the person operates.
Can they work without a large support infrastructure?
Can they shift priorities quickly?
Will they identify a problem and take ownership of resolving it?
Are they comfortable challenging a CRO?
Can they communicate directly with senior leadership?
Can they remain hands-on while also thinking strategically?
Have they built something before, rather than simply inherited an established process?
These questions are particularly important when identifying senior people who will serve as the foundational members – the core pillars – of a growing organization.
They also help hiring teams assess whether a candidate's experience will translate into the specific operating environment they are entering.
Hiring for the Environment, Not Just the Job Description
Reducing hiring risk starts with understanding what success really looks like inside the organization.
Before beginning a search, companies should consider:
Stage of development: A Phase I biotech and a company preparing for an NDA may require very different experience.
Operating model: Is most of the work internal, outsourced to CROs, or managed through a hybrid model?
Infrastructure: Does the organization have established systems and SOPs, or will the new hire need to build them?
Level of ownership: Is this person overseeing the work or expected to execute it themselves?
Company size: Has the candidate successfully operated in an organization with similar resources and expectations?
Urgency: Does the candidate demonstrate the pace and accountability required in an emerging biotech?
Technical experience remains critical. But the best hire is the person whose experience, mindset, and working style align with the environment they are entering.
That alignment can be especially important when evaluating senior biometrics hires who will be expected to work across functions, manage external partners, and contribute directly to critical development milestones.
How Orbis Clinical Helps Reduce Risk in Biometrics Hires
For life sciences companies, assessing this kind of fit can be difficult when an internal team is already balancing study timelines, CRO oversight, and regulatory priorities. Orbis Clinical brings specialized life sciences expertise to that process, with experience across Clinical Data Management, Statistical Programming, and Biostatistics.
Orbis approaches staffing by first understanding the program, the organization's internal expertise, the responsibilities held by CROs and other vendors, and where specialized support is needed. That context helps inform whether a company needs an individual consultant, contract-to-hire or permanent talent, fractional expertise, or a broader FSP model.
That program-level understanding also informs candidate evaluation. Orbis has developed long-term relationships with life sciences organizations by learning their systems, cultures, hiring preferences, and functional needs. Its specialized expertise across Biometrics helps clients identify professionals whose technical experience and working style align with the needs of the organization and the demands of the program.
Orbis also remains involved after placement through consultant check-ins, performance discussions, onboarding support, early issue resolution, and ongoing communication with managers and Talent Acquisition. For clients, that creates an additional layer of support when the goal is not simply to make a placement, but to build a resource that can contribute effectively within the organization.
For organizations with broader or evolving needs, Orbis can also provide FSP support. Its OC Link FSP model has helped sponsors add scalable resources across functional areas while accounting for expertise and culture fit.
The Bottom Line: Alignment Can Protect the Program
In Biometrics, companies cannot afford to evaluate candidates solely by what appears on a résumé.
The strongest technical candidate is not necessarily the strongest hire.
For emerging biotech in particular, success often depends on finding people who combine deep functional expertise with urgency, adaptability, accountability, and the willingness to operate outside of traditional functional boundaries.
Getting that alignment right can help prevent rework, protect development timelines, strengthen CRO oversight, and ultimately reduce risk as a program moves toward regulatory submission.
Because when a critical Biometrics hire is truly aligned with the company, they do more than fill a position.
They help keep the program moving forward.
If you are evaluating biometrics hires for an emerging biotech or need additional expertise across Biostatistics, Statistical Programming, or Clinical Data Management, Orbis Clinical can help you assess the experience and staffing model that best fits your program. Contact Orbis Clinical to discuss your biometrics hiring needs.
About the Author
With more than 30 years of staffing experience, including 15+ years dedicated to the life sciences industry, Paul Canelas specializes in connecting top talent with organizations across pharmaceutical, biotechnology, cell and gene therapy, medical device, CRO, CDMO, and CMO sectors.
He delivers contract, contract-to-hire, direct placement, and project-based staffing solutions, supporting functions including clinical research, regulatory affairs, biometrics, pharmacovigilance, quality, manufacturing, medical affairs, commercial operations, and executive leadership. Combining deep industry knowledge with an extensive network, Paul is committed to helping companies build high-performing teams and professionals advance their careers.
DELIVERED TO YOUR INBOX MONTHLY